DocGo ‘categorically rejects’ short seller report

DocGo said it “categorically rejects this purported assessment by Fuzzy Panda Research, an obscure short seller motivated solely by profit.” The company added in a press release: “Their so-called ‘research report’ uses what appears to be old, public information to present an overall picture of DocGo and its business that is false, misleading and defamatory, and we intend to issue a cease-and-desist letter to the firm and are exploring all available legal means to respond. We believe this short seller is focused on personal financial gain at the expense of DocGo’s shareholders, employees, customers and other stakeholders. In stark contrast to the implications contained in this inflammatory and misleading “report,” DocGo’s business continues to grow.”